Press Releases April 28, 2026 09:00 AM

LPL Financial Launches Military Deployment Practice Continuation Program

LPL Financial launches program to support military-affiliated advisors during active duty deployments

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
LPLA

LPL Financial announced the launch of its Military Deployment Practice Continuation Program, designed to help financial advisors who serve in the U.S. Armed Forces maintain the stability and value of their practices while on active duty. The program offers advisors options for practice continuity, including designating a qualified partner or LPL itself to manage their book of business during deployment, with revenue-sharing to protect advisors' long-term interests and ensure uninterrupted client service.

LPL Financial Launches Military Deployment Practice Continuation Program
LPLA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Introduction of a new support program for LPL-affiliated advisors serving in the military to maintain practice continuity during active duty deployments.
  • Program allows advisors to designate a continuity partner or LPL to manage client relationships and revenue streams during their absence.
  • Reinforces LPL's commitment to advisor stability, client care, and long-term continuity planning within the wealth management sector.

SAN DIEGO, April 28, 2026 (GLOBE NEWSWIRE) -- LPL Financial LLC (Nasdaq:LPLA) today announced the launch of its Military Deployment Practice Continuation Program, a new support framework designed to help eligible LPL-affiliated financial advisors who serve in the U.S. Armed Forces maintain the value and stability of their practices when they are called to active duty.

When advisors enter active military service, FINRA designates them as inactive under its Active Military Leave policy, temporarily pausing certain registration requirements. During this period, LPL’s new program provides a structured, turnkey approach to help ensure clients continue receiving consistent, uninterrupted service throughout an advisor’s deployment and for up to 90 days after they return.

A central feature of the program is the ability for advisors to designate a qualified continuity partner — or, if needed, LPL itself — to support their book of business while they are deployed. Throughout the deployment, advisors continue to receive revenue through an agreed-upon percentage split, helping safeguard the long-term health of their practices during extended absences.

“Financial advisors who answer the call to serve their country should not have to choose between fulfilling their military duty and protecting the future of their practice,” said Jeremy Holly, executive vice president of LPL Capital Partners. “Our Military Deployment Practice Continuation Program provides clarity, structure and continuity — for advisors, their clients and the partners who support them — during what can be an incredibly challenging transition.”

The program clearly outlines operational steps and protections, including revenue-sharing guidance, state registration considerations, carrier processing timelines and support for returning to active status with FINRA after deployment. It also aligns with LPL’s broader continuity-planning framework, which includes established death and disability agreements to help advisors prepare for unexpected life events.

By formalizing this deployment-related support, LPL strengthens its ongoing commitment to military-affiliated advisors, veterans and the broader advisor community, reinforcing the firm’s focus on advisor stability, client care and long-term continuity planning.

Advisors can learn more about the Military Deployment Practice Continuation Program by contacting [email protected].

About LPL Financial

LPL Financial Holdings Inc. (Nasdaq: LPLA) is among the fastest growing wealth management firms in the U.S. As a leader in the financial advisor-mediated marketplace, LPL supports over 32,000 financial advisors and the wealth management practices of approximately 1,200 financial institutions, servicing and custodying approximately $2.4 trillion in brokerage and advisory assets on behalf of approximately 8 million Americans. The firm provides a wide range of advisor affiliation models, investment solutions, fintech tools and practice management services, ensuring that advisors and institutions have the flexibility to choose the business model, services and technology resources they need to run thriving businesses. For further information about LPL, please visit www.lpl.com.

Securities and advisory services offered through LPL Financial LLC (“LPL Financial”), a registered investment advisor and broker-dealer, member FINRA/SIPC.

Throughout this communication, the terms “financial advisors” and “advisors” are used to refer to registered representatives and/or investment advisor representatives affiliated with LPL Financial. 

We routinely disclose information that may be important to shareholders in the “Investor Relations” or “Press Releases” section of our website. 

Media Contact: 
[email protected] 
(402) 740-2047 

Tracking #: 1098360


Risks

  • Potential regulatory challenges related to managing client assets and advisor licensing during active military service.
  • Operational risks in ensuring seamless service and compliance across different states during advisor deployments.
  • Dependence on the engagement of continuity partners and the effectiveness of the revenue-sharing framework to keep advisors financially stable.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026